Quanttus: Why continuous blood pressure monitoring is a game-changer

June 05,2024

Quanttus's original research device. The current prototype is worn on the wrist. Quanttus, the stealthy Cambridge, Massachusetts-based startup that raised $19 million last year for a wearable vitals monitor is deep into clinical tests for its wristworn device, which is tackling the intractable problem of continuous blood pressure monitoring. "Cardiovascular disease is the number one killer in the US, and it hits more than all cancers and AIDS combined," David He, cofounder and chief scientific officer of Quanttus, said at the HxRefactored event last week.

From Cuff To Cuffless: The Evolution Of Blood Pressure Monitoring

24 hours ambulatory NIBP monitoring function, up to 350 groups of ambulatory NIBP data can be recorded for once.Perfect combination of automatic and

CONTEC ABPM50 Ambulatory Blood Pressure Monitor 24 Hours Holter with PC Software for Continuous Monitoring+USB Port

How to Invest in Biometrics

Inside Wearables Part 2: Key developments for adoption and engagement, by Endeavour Partners

Resources Archives - NextView Ventures

WO2004034221A9 - Apparatus for detecting, receiving, deriving and displaying human physiological and contextual information - Google Patents

ABPM50 is a handheld ambulatory blood pressure monitor,The device could monitor human body blood pressure up to 24 hours continuously and dynamically,

CONTEC ABPM50 Handheld 24hours Ambulatory Blood Pressure Monitor with PC Software for Continuous Monitoring NIBP USB Port with Three Cuffs

Sensors, Free Full-Text

Moving From Digitalization to Digitization in Cardiovascular Care: Why Is it Important, and What Could it Mean for Patients and Providers?

Quanttus: Blood pressure startup alums at Apple, , Verily, Nike

ECG and Blood Pressure Monitoring: The Game Changer in Wearable Techno – QUANTYVO

What's the Future of Blood Pressure Monitoring? - Penn Medicine